Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Page 1
Management of Indwelling Tunneled Pleural Catheters: A Modified Delphi Consensus Statement.
Gilbert CR, Wahidi MM, Light RW, Rivera MP, Sterman DH, Thomas R, Shojaee S, Shoham S, Psallidas I, Ost DE, Molena D, Maskell N, Maldonado F, Liberman M, Lee YCG, Lee H, Herth FJF, Grosu H, Gorden JA, Fysh ETH, Corcoran JP, Argento AC, Akulian JA, Rahman NM, Yarmus LB; Interventional Pulmonary Outcomes Group. Gilbert CR, et al. Among authors: rivera mp. Chest. 2020 Nov;158(5):2221-2228. doi: 10.1016/j.chest.2020.05.594. Epub 2020 Jun 17. Chest. 2020. PMID: 32561437
RESEARCH QUESTION: Our objective was to formulate clinical consensus statements related to perioperative and long-term IPC catheter management based on a modified Delphi process from experts in pleural disease management. ...This statement offers statements for care in num …
RESEARCH QUESTION: Our objective was to formulate clinical consensus statements related to perioperative and long-term IPC catheter m …
Long-term follow-up of a phase I/II trial of dose escalating three-dimensional conformal thoracic radiation therapy with induction and concurrent carboplatin and paclitaxel in unresectable stage IIIA/B non-small cell lung cancer.
Stinchcombe TE, Lee CB, Moore DT, Rivera MP, Halle J, Limentani S, Rosenman JG, Socinski MA. Stinchcombe TE, et al. Among authors: rivera mp. J Thorac Oncol. 2008 Nov;3(11):1279-85. doi: 10.1097/JTO.0b013e31818b1971. J Thorac Oncol. 2008. PMID: 18978563 Free article. Clinical Trial.
The 5-year progression-free survival and OS rates were 21% (12-32%) and 27% (17-39%), respectively. The 10-year OS rate was 14% (7-25%). CONCLUSION: The long term survival rate compares favorably to other treatment approaches for stage III non-small cell lung cancer....
The 5-year progression-free survival and OS rates were 21% (12-32%) and 27% (17-39%), respectively. The 10-year OS rate was 14% (7-25%). CON …
Multimodality therapy in the treatment of lung cancer.
Rivera MP. Rivera MP. Semin Respir Crit Care Med. 2004;25 Suppl 1:3-10. doi: 10.1055/s-2004-829639. Semin Respir Crit Care Med. 2004. PMID: 16088515
Although cure rates are modest and variable in locally advanced NSCLC, multimodality therapy (chemotherapy in combination with surgery or radiotherapy) has resulted in statistically significant improvement in 5-year survival when compared with surgery or radiotherapy alone. Patie …
Although cure rates are modest and variable in locally advanced NSCLC, multimodality therapy (chemotherapy in combination with surgery or ra …
Chromosomal abnormalities in bronchial epithelium from smokers, nonsmokers, and lung cancer patients.
Slebos RJ, Livanos E, Yim HW, Randell SH, Parsons AM, Detterbeck FC, Rivera MP, Taylor JA. Slebos RJ, et al. Among authors: rivera mp. Cancer Genet Cytogenet. 2005 Jun;159(2):137-42. doi: 10.1016/j.cancergencyto.2004.10.008. Cancer Genet Cytogenet. 2005. PMID: 15899385
To study the use of karyotypes for this purpose, we used short-term human bronchial epithelial (hBE) cell cultures from nonsmokers, smokers, and lung cancer patients. ...
To study the use of karyotypes for this purpose, we used short-term human bronchial epithelial (hBE) cell cultures from nonsmokers, s …